Toon Van Gorp
Toon Van Gorp
Professor of Gynaecological Oncology @ University of Leuven
Verified email at uzleuven.be
Title
Cited by
Cited by
Year
HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm
T Van Gorp, I Cadron, E Despierre, A Daemen, K Leunen, F Amant, ...
British journal of cancer 104 (5), 863-870, 2011
3162011
Endometriosis and the development of malignant tumours of the pelvis. A review of literature
T Van Gorp, F Amant, P Neven, I Vergote, P Moerman
Best practice & research Clinical obstetrics & gynaecology 18 (2), 349-371, 2004
3072004
Ovarian cancer
N Colombo, T Van Gorp, G Parma, F Amant, G Gatta, C Sessa, I Vergote
Critical reviews in oncology/hematology 60 (2), 159-179, 2006
2882006
Management of borderline ovarian neoplasms
I Cadron, K Leunen, T Van Gorp, F Amant, P Neven, I Vergote
Journal of clinical oncology 25 (20), 2928-2937, 2007
2502007
Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer: safety, recurrence, and long-term outcome
I Kalogiannidis, S Lambrechts, F Amant, P Neven, T Van Gorp, I Vergote
American journal of obstetrics and gynecology 196 (3), 248. e1-248. e8, 2007
1322007
Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant …
T Van Gorp, J Veldman, B Van Calster, I Cadron, K Leunen, F Amant, ...
European journal of cancer 48 (11), 1649-1656, 2012
1212012
Timing of debulking surgery in advanced ovarian cancer
I Vergote, T Van Gorp, F Amant, K Leunen, P Neven, P Berteloot
International Journal of Gynecologic Cancer 18 (Suppl 1), 2008
1082008
Lymph node metastasis in stages I and II ovarian cancer: a review
M Kleppe, T Wang, T Van Gorp, BFM Slangen, AJ Kruse, R Kruitwagen
Gynecologic oncology 123 (3), 610-614, 2011
1032011
Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients
IJG Rutten, DPJ van Dijk, RFPM Kruitwagen, RGH Beets‐Tan, ...
Journal of cachexia, sarcopenia and muscle 7 (4), 458-466, 2016
982016
Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance—a study of the OVCAD consortium
E Obermayr, DC Castillo-Tong, D Pils, P Speiser, I Braicu, T Van Gorp, ...
Gynecologic oncology 128 (1), 15-21, 2013
982013
Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive
B Van Calster, IV Bempt, M Drijkoningen, N Pochet, J Cheng, ...
Breast cancer research and treatment 113 (1), 181-187, 2009
932009
Subjective assessment versus ultrasound models to diagnose ovarian cancer: A systematic review and meta-analysis
EMJ Meys, J Kaijser, R Kruitwagen, BFM Slangen, B Van Calster, ...
European journal of cancer 58, 17-29, 2016
812016
Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA–IV: analysis of the OVCAD data
S Polterauer, I Vergote, N Concin, I Braicu, R Chekerov, S Mahner, ...
International Journal of Gynecologic Cancer 22 (3), 2012
802012
Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients: results from the OVCAD study
EI Braicu, C Fotopoulou, T Van Gorp, R Richter, R Chekerov, C Hall, ...
Gynecologic oncology 128 (2), 245-251, 2013
742013
Robotic retroperitoneal lower para-aortic lymphadenectomy in cervical carcinoma: first report on the technique used in 5 patients
I Vergote, B Pouseele, T Van Gorp, B Van Acker, K Leunen, I Cadron, ...
Acta obstetricia et gynecologica Scandinavica 87 (7), 783-787, 2008
742008
The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma—analysis of patient data in the …
G Hofstetter, N Concin, I Braicu, R Chekerov, J Sehouli, I Cadron, ...
Gynecologic oncology 131 (1), 15-20, 2013
732013
Psoas muscle area is not representative of total skeletal muscle area in the assessment of sarcopenia in ovarian cancer
IJG Rutten, J Ubachs, RFPM Kruitwagen, RGH Beets‐Tan, ...
Journal of cachexia, sarcopenia and muscle 8 (4), 630-638, 2017
722017
Chemotherapy for recurrent cervical cancer
I Cadron, T Van Gorp, F Amant, K Leunen, P Neven, I Vergote
Gynecologic oncology 107 (1), S113-S118, 2007
692007
Laparoscopy to predict the result of primary cytoreductive surgery in patients with advanced ovarian cancer: a randomized controlled trial
MJ Rutten, HS Van Meurs, R Van De Vrie, CA Naaktgeboren, G Fons, ...
Journal of Clinical Oncology 35 (6), 613-621, 2017
672017
A comparison between an ultrasound based prediction model (LR2) and the risk of ovarian malignancy algorithm (ROMA) to assess the risk of malignancy in women with an adnexal mass
J Kaijser, T Van Gorp, K Van Hoorde, C Van Holsbeke, A Sayasneh, ...
Gynecologic oncology 129 (2), 377-383, 2013
622013
The system can't perform the operation now. Try again later.
Articles 1–20